Diagnosis associated with COVID-19 (U07.1), pneumonia- unspecified (J18. 9) and other types of admissions: A restricted medical scheme case study-South Africa
E3 J. Med. Res
;
8(1): 1-16, 2021. figures, tables
Artigo
em Inglês
| AIM
| ID: biblio-1368199
ABSTRACT
The primary objective of this study was to assess the characteristics of patients admitted for COVID-19, 'J18.9 Pneumonia, unspecified organism' and other types of diagnoses. The aim was to assess as to what extent do COVID-19 related admissions changed to pneumonia, and as to what extent do 'J18.9 Pneumonia, unspecified organism' related admissions that changed to COVID-19 diagnosis at discharge stage. The secondary objective of the study was to assess' predictors of readmissions in private hospitals. The review period was private hospital claims received by the scheme between January and August 2020. The inclusion criteria for COVID-19 admissions were patients that had a laboratory-confirmed (RT ? PCR assay) COVID-19. Predictors of readmissions were modelled using logistic regression. The study found that restricted scheme patients admitted for a COVID-19 diagnosis changed to a 'J18.9 Pneumonia, unspecified organism' diagnosis. The converse was found to be true in that some patients that were admitted as J18.9 Pneumonia, unspecified organism' diagnosis changed to a COVID-19 diagnosis. This study showed underlying factors associated with hospital admissions and predictors of readmissions in private hospitals.
Texto completo:
DisponíveL
Índice:
AIM (África)
Assunto principal:
Admissão do Paciente
/
Pneumonia
/
Fatores de Risco
/
Diagnóstico
/
COVID-19
Tipo de estudo:
Estudo diagnóstico
/
Estudo de etiologia
/
Estudo prognóstico
/
Fatores de risco
Idioma:
Inglês
Revista:
E3 J. Med. Res
Ano de publicação:
2021
Tipo de documento:
Artigo
Instituição/País de afiliação:
Policy Research and Monitoring, Council for Medical Schemes/ZA
/
Sefako Makgatho Health Sciences University, Ga-Rankuwa/ZA
Similares
MEDLINE
...
LILACS
LIS